NDA 003444 · Esjay Pharma
Drisdol
Ergocalciferol · Oral · Provitamin D2 Compound
Last checked: Nov 20, 2026Latest source record: Nov 20, 2003 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1941
Jan 11, 1941
Approved uses
1
Original approval plus efficacy supplements
Registered trials
96
10 Phase 3, 2 recruiting
FAERS reports
29,734
24,323 serious, 4,036 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Sep 4, 2026.
INDICATIONS AND USAGE Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jan 11, 1941 Original approval
1 products under this application
- DRISDOL · ERGOCALCIFEROL 50,000 IU · CAPSULE, ORAL · Prescription · TE AA
Clinical trials
Interventional ClinicalTrials.gov studies with "Ergocalciferol" as an intervention, any sponsor and status, largest first.
- Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and MalnutritionPivotal-lookingStatus unknown
Wenhu LiuAcademic, hospital or other
NCT02005302 · 600 participants (planned) · Start Jan 2013 · Primary completion Dec 2015
Drug: 1,25(OH)2 Vitamin D3; Vitamin D2 · For: Vitamin D Deficiency; Malnutrition
Sites: Beijing, China · 5 sites in all
- A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D SupplementationPivotal-lookingStatus unknown
First Affiliated Hospital Xi'an Jiaotong UniversityAcademic, hospital or other
NCT05549154 · 372 participants (planned) · Start Dec 5, 2022 · Primary completion Aug 1, 2023
Drug: High-dose vitamin D2 softgels; low-dose vitamin D2 softgels and 1 more · For: Chronic Kidney Disease 5D; Secondary Hyperparathyroidism Due to Renal Causes; Vitamin D Deficiency
Sites: Xi'an, China
- Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in AdultsPivotal-lookingStatus unknown
Chulalongkorn UniversityAcademic, hospital or other
NCT03228862 · 360 participants · Start May 1, 2017 · Primary completion Feb 1, 2018
Drug: Ergocalciferol · For: Vitamin D2 Supplementation in Vitamin D Insufficiency
Sites: Bangkok, Thailand
- Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD PatientsPivotal-lookingStatus unknown
Peking University People's HospitalAcademic, hospital or other
NCT01672047 · 350 participants (planned) · Start Apr 2012 · Primary completion Apr 2014
Drug: Vitamin D2 · For: Chronic Kidney Disease; Vitamin D Deficiency
Sites: Beijing, China
- Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory InfectionPivotal-lookingStatus unknown
University of LimpopoAcademic, hospital or other
NCT02054182 · 320 participants (planned) · Start Feb 2014 · Primary completion Nov 2014
Drug: Vitamin D · For: Acute Lower Respiratory Tract Infection; Pneumonia; Bronchiolitis
Sites: Pretoria, South Africa
- Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation StrategyPivotal-lookingCompleted
Case Western Reserve UniversityAcademic, hospital or other
NCT01601847 · 300 participants · Start Jan 2013 · Primary completion Mar 12, 2017
Drug: Cholecalciferol · For: Wheezing; Allergy
Sites: New York, New York; Cleveland, Ohio; Charleston, South Carolina · 5 sites in all
- Effect of Vitamin D Oral Supplements on 25 OH Vitamin D LevelsPivotal-lookingCompleted
King Faisal Specialist Hospital & Research CenterAcademic, hospital or other
NCT01170494 · 279 participants · Start Feb 2013 · Primary completion Apr 2016
Drug: ergocalciferol 2000 IU orally, daily; ergocalciferol 25000 IU oraly every 2 weeks and 6 more · For: Vitamin D Deficiency
Sites: Riyadh, Saudi Arabia
- Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast caPivotal-lookingStatus unknown
King Faisal Specialist Hospital & Research CenterAcademic, hospital or other
NCT00944424 · 260 participants (planned) · Start Jul 2009 · Primary completion Jul 2012
Drug: Docetaxel + High dose Vitamin D2; Docetaxel + Standard dose Vitamin D2 · For: Breast Cancer
Sites: Kuwait City, Kuwait; Riyadh, Saudi Arabia; Jeddah, Saudi Arabia · 6 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective4,722
- fatigue4,457
- pain4,365
- off label use4,267
- dyspnoea4,230
- nausea3,812
- headache3,802
- diarrhoea3,584
- vomiting3,574
- arthralgia3,442
- condition aggravated3,340
- drug hypersensitivity3,203
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 104 |
| 2005 | 95 |
| 2006 | 87 |
| 2007 | 109 |
| 2008 | 310 |
| 2009 | 302 |
| 2010 | 402 |
| 2011 | 354 |
| 2012 | 461 |
| 2013 | 376 |
| 2014 | 453 |
| 2015 | 706 |
| 2016 | 1,165 |
| 2017 | 1,578 |
| 2018 | 1,671 |
| 2019 | 2,363 |
| 2020 | 2,511 |
| 2021 | 2,950 |
| 2022 | 3,298 |
| 2023 | 2,986 |
| 2024 | 3,276 |
| 2025 | 2,758 |
| 2026 | 1,417 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Intestinal absorption of vitamin D: a systematic review.
Silva MC, Furlanetto TW · Nutr Rev 2018 · Research Support, Non-U.S. Gov't, Systematic Review
- Comparison of the Effect of Daily Vitamin D2 and Vitamin D3 Supplementation on Serum 25-Hydroxyvitamin D Concentration (Total 25(OH)D, 25(OH)D2, and 25(OH)D3) and Importance of Body Mass Index: A Systematic Review and Meta-Analysis.
van den Heuvel EG, Lips P, Schoonmade LJ, et al. · Adv Nutr 2024 · Meta-Analysis, Systematic Review
- Calcium and vitamin D for increasing bone mineral density in premenopausal women.
Méndez-Sánchez L, Clark P, Winzenberg TM, et al. · Cochrane Database Syst Rev 2023 · Research Support, Non-U.S. Gov't, Systematic Review
- Is Vitamin D Supplementation Useful for Weight Loss Programs? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Perna S · Medicina (Kaunas) 2019 · Meta-Analysis, Systematic Review
- An evidence-based review of systemic treatments for itch.
Pongcharoen P, Fleischer AB · Eur J Pain 2016 · Meta-Analysis, Systematic Review
- Feasibility of intervention in elder self-neglecters: Setting the stage for future research.
Lee JL, Burnett J, Xia R, et al. · J Elder Abuse Negl 2018 · Randomized Controlled Trial, Research Support, N.I.H., Extramural
Sponsor: Esjay Pharma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.